Method of treating lung disease with uridine triphosphates
US5292498A · kind A · utility
106Cited by
3References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 19, 1991 |
| Grant date | Mar 8, 1994 |
| Priority date | — |
| Expiry date | Jun 19, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of hydrating mucous secretions in the lungs of a subject in need of such treatment is disclosed. The method comprises administering to the lungs of the subject a uridine triphosphate such as uridine 5'-triphosphate (UTP) or uridine 5'-O-(3-thiotriphosphate) (UTP.gamma.S) in an amount effective to hydrate lung mucous secretions. The method is useful for treating patients aflicted with cystic fibrosis. Pharmaceutical formulations and methods of making the same are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.